EMBC - Embecta Corp.
9.71
-0.280 -2.884%
Share volume: 973,125
Last Updated: 03-03-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$9.99
-0.28
-0.03%
Fundamental analysis
64%
Profitability
81%
Dept financing
43%
Liquidity
35%
Performance
60%
Performance
5 Days
-5.36%
1 Month
-14.45%
3 Months
-16.87%
6 Months
-32.99%
1 Year
-22.94%
2 Year
-30.24%
Key data
Stock price
$9.71
DAY RANGE
$9.59 - $9.94
52 WEEK RANGE
$9.20 - $15.55
52 WEEK CHANGE
-$25.31
DIVIDEND
$0.15
EX-DIVIDEND DATE
02-28-2025
NEXT EARNINGS DATE
05-08-2025
Company detail
CEO: Devdatt Kurdikar
Region: US
Website: embecta.com
Employees: 1,900
IPO year: 2022
Issue type:
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
Region: US
Website: embecta.com
Employees: 1,900
IPO year: 2022
Issue type:
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
Embecta Corp. focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications. The company primarily sells its products to wholesalers and distributors in the United States and internationally.
Recent news